No. |
Drug (Description in trials) |
DrugBank |
KEGG DRUG * |
KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 |
Alkaline phosphatase |
Alkaline phosphatase |
- |
- |
- |
[3] 46, 97, 172 |
2 |
Asfotas alfa |
- |
- |
- |
- |
[1] 172 |
3 |
Asfotase alfa |
Asfotase alfa |
D10595 |
[1] ALPL |
[3] Folate biosynthesis, Metabolic pathways, Thiamine metabolism |
[1] 172 |
4 |
Bps804 |
- |
- |
- |
- |
[2] 172, 274 |
5 |
Cyclophosphamide |
Cyclophosphamide |
D00287, D07760 |
- |
- |
[43] 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 61, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 |
6 |
Enb-0040 |
- |
- |
- |
- |
[1] 172 |
7 |
Fully human igg2 lambda monoclonal antibody |
- |
- |
- |
- |
[1] 172 |
8 |
Human recombinant tissue non-specific alkaline phosphatase fusion protein |
Alkaline phosphatase |
- |
- |
- |
[1] 172 |
9 |
Methotrexate |
Methotrexate |
D00142, D02115 |
[2] DHFR, DHFR2 |
[4] Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
10 |
Retrospective case only |
- |
- |
- |
- |
[1] 172 |
11 |
Same |
Ademetionine |
D07128 |
- |
- |
[15] 6, 14, 22, 43, 44, 46, 47, 49, 50, 60, 84, 93, 96, 97, 172 |
12 |
Strensiq |
Asfotase alfa |
D10595 |
[1] ALPL |
[3] Folate biosynthesis, Metabolic pathways, Thiamine metabolism |
[1] 172 |